A Novel Metric for Assessing Long-Term Outcomes in Adults with Chiari Malformation Type I: Occipitocervical Dura Angulation (ODA)-Applications and Value
- PMID: 40451958
- DOI: 10.1007/s12311-025-01865-4
A Novel Metric for Assessing Long-Term Outcomes in Adults with Chiari Malformation Type I: Occipitocervical Dura Angulation (ODA)-Applications and Value
Abstract
Foramen magnum decompression with duraplasty (FMDD), a common surgery for adult Chiari malformation type I(CM-I) with a 60-70% improvement rate, lacks assessment metrics. This study applied the concept of occipitocervical dura angulation (ODA) and aimed to investigate ODA's role in evaluating long-term FMDD outcomes. The ODA normal range was measured in 230 healthy individuals. We included 160 CM-I adults who underwent FMDD over 10 years. Long-term outcomes (> 1 year) were evaluated using the Chicago Chiari Outcome Scale(CCOS). The cohort was grouped to analyze ODA's role in assessing and predicting FMDD outcomes. The normal range of ODA was 104°-145°, with an average value of 124.2 ± 10.4°. The median patient age was 46 years (range: 18-64 years). The median follow-up period was 64.5 months (range: 18-123 months). The cohort was divided into two groups based on preoperative ODA: group A (n = 90) with ODA < 125° and group B (n = 70) with ODA ≥ 125°. Group B had a significantly better prognosis than that of group A (P = 0.012). Logistic regression analysis revealed that an increase in ODA was associated with clinical outcomes in both groups. The receiver operating characteristic curve showed that ODA increases of > 10° and > 3° could be considered as credible threshold values for groups A and B, respectively. ODA is a reliable predictor of prognosis. FMDD should result in an increased ODA, which is one of the criteria for surgical validity, especially for those with a preoperative ODA of < 125°.
Keywords: Chiari malformation type I; Long-term Outcomes; Occipitocervical dura angulation.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: This retrospective study followed the principles of the Declaration of Helsinki. This study was approved by institutional review boards of Beijng Tiantan Hospital, Capital Medical University. Consent to Participate: Informed consent was obtained from all individual participants included in the study. Competing Interests: The authors declare no competing interests.
References
-
- Wilkinson DA, Johnson K, Garton HJ, Muraszko KM, Maher CO. Trends in surgical treatment of Chiari malformation type I in the united States. J Neurosurg Pediatr. 2017;19(2):208–16. https://doi.org/10.3171/2016.8.PEDS16273 . - DOI - PubMed
-
- Dyste GN, Menezes AH, VanGilder JC. Symptomatic Chiari malformations. An analysis of presentation, management, and long-term outcome. J Neurosurg. 1989;71(2):159–68. https://doi.org/10.3171/jns.1989.71.2.0159 . - DOI - PubMed
-
- Doberstein CA, Torabi R, Klinge PM. Current concepts in the pathogenesis, diagnosis, and management of type I Chiari malformations. R I Med J (2013). 2017;100(6):47–9. Published 2017 Jun 1. - PubMed
-
- Buell TJ, Heiss JD, Oldfield EH. Pathogenesis and cerebrospinal fluid hydrodynamics of the Chiari I malformation. Neurosurg Clin N Am. 2015;26(4):495–9. https://doi.org/10.1016/j.nec.2015.06.003 . - DOI - PubMed - PMC
-
- Williams B. Pathogenesis of Syringomyelia. Acta Neurochir (Wien). 1993;123(3–4):159–65. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical